GleamWall
中文EN

UFPT UFP TECHNOLOGIES INC

Surgical & Medical Instruments & Apparatus · Nasdaq · SEC CIK 914156 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY8.6%
TTM net income YoY14.0%
TTM EPS YoY13.7%
Revenue 3-yr CAGR18.6%
Net income 3-yr CAGR22.4%

Margins

Gross margin28.9%
Operating margin15.5%
Net margin11.8%
FCF margin—
EBITDA margin18.5%

Returns

ROE17.2%
ROA11.5%
ROIC (approx.)15.0%
Asset turnover0.97x

Leverage & solvency

Liabilities / assets28.8%
Debt / equity0.20x
Current ratio2.98x
Interest coverage14.64x

Cash quality & payout

Operating cash flow / net income0.97x
Accruals ratio0.3%
Payout ratio—
Capex / revenue—

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31
Income statement
Revenue$602.80M$504.42M
Cost of revenue$432.39M$357.73M
Gross profit$170.41M$146.69M
R&D expense$8.60M$10.40M
SG&A expense$77.44M$62.22M
Operating income$92.34M$80.90M
Interest expense$9.80M$8.06M
Pretax income$82.51M$73.03M
Income tax$14.20M$14.04M
Net income$68.31M$58.98M
EBITDA$111.49M$95.61M
EPS (basic)8.877.69
EPS (diluted)8.757.58
Weighted avg. shares (diluted)7.80M7.79M
Balance sheet
Cash & equivalents$20.30M$13.45M
Receivables$82.91M$84.68M
Inventory$86.86M$87.54M
Current assets$201.00M$194.94M
PP&E, net$79.11M$70.56M
Goodwill$197.40M$189.66M
Intangibles$140.85M$144.25M
Total assets$655.08M$629.00M
Current liabilities$74.86M$76.30M
Short-term debt$12.50M$12.50M
Long-term debt$122.95M$176.88M
Total debt$135.46M$189.38M
Total liabilities$231.20M$286.24M
Shareholders' equity$423.88M$342.76M
Net debt$115.15M$175.93M
Shares outstanding7.71M7.68M
Cash flow statement
Operating cash flow$91.91M$66.59M
Capital expenditure—$9.66M
Free cash flow—$56.94M
Investing cash flow-$27.60M-$210.16M
Financing cash flow-$58.16M$152.39M
Depreciation & amortization$19.15M$14.71M
Stock-based compensation$8.85M$6.84M

Free plan shows the latest 2 periods; Pro shows all 17 🔒

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.